| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Psychosomatic Medicine, Vol 52, Issue 5 496-510, Copyright © 1990 by American Psychosomatic Society
ORIGINAL ARTICLES |
MH Antoni, S August, A LaPerriere, HL Baggett, N Klimas, G Ironson, N Schneiderman and MA Fletcher
Department of Psychology, University of Miami, Coral Gables, FL 33124-2070.
Our previous work indicated that gay males ultimately found to be seronegative showed impaired lymphocyte proliferative responses to phytohemagglutinin (PHA) and pokeweed mitogen (PWM) upon entering a study in which they would be notified of their human immunodeficiency virus-Type 1 (HIV-1) antibody status. To examine the degree to which alterations in various neuroendocrine and psychological markers might be related to this phenomenon we measured plasma cortisol, beta-endorphin, denial coping strategies, intrusive thoughts related to AIDS risk, and several affective distress markers in 46 HIV-1 seronegative subjects at each of the timepoints previously studied. Results indicated that cortisol levels were elevated at study entry and decreased across the subsequent five-week period--mirroring the changes in mitogen responsivity across these timepoints. Analyses of individual differences showed that higher baseline cortisol and lower denial coping scores predicted lower PHA values at baseline. Persisting intrusive thoughts about risk of HIV-1 infectivity (after seronegativity notification) were consistently associated with higher plasma cortisol levels. Finally, beta-endorphin levels did not change significantly across the 10-week observation period, were not associated with psychological variables, and were inconsistently associated with immune functioning.
This article has been cited by other articles:
![]() |
M. Robbins, J. Szapocznik, M. Tejeda, D. Samuels, G. Ironson, and M. Antoni The Protective Role of the Family and Social Support Network in a Sample of HIV-Positive African American Women: Results of a Pilot Study. Journal of Black Psychology, February 1, 2003; 29(1): 17 - 37. [Abstract] [PDF] |
||||
![]() |
J. K. Kiecolt-Glaser, L. McGuire, T. F. Robles, and R. Glaser Psychoneuroimmunology and Psychosomatic Medicine: Back to the Future Psychosom Med, January 1, 2002; 64(1): 15 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cruess, M. Antoni, D. Cruess, M. A. Fletcher, G. Ironson, M. Kumar, S. Lutgendorf, A. Hayes, N. Klimas, and N. Schneiderman Reductions in Herpes Simplex Virus Type 2 Antibody Titers After Cognitive Behavioral Stress Management and Relationships With Neuroendocrine Function, Relaxation Skills, and Social Support in HIV-Positive Men Psychosom Med, December 1, 2000; 62(6): 828 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bennett and C. Lengacher Design and Testing of a Complementary Therapy Rating Scale in Rural Persons with Cancer Complementary Health Practice Review, October 1, 1998; 4(3): 179 - 195. [Abstract] [PDF] |
||||
![]() |
M. H. Antoni Phenomenology of HIV-1: A Stress Moderator Model The Counseling Psychologist, October 1, 1991; 19(4): 543 - 550. |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |